Evidence map›Paper›PMID 40468311›Full record

ReviewCell communication and signaling : CCS2025

Apoptosis-inducing factor (AIF) at the crossroad of cell survival and cell death: implications for cancer and mitochondrial diseases.

Tran Ngoc Anh Nguyen, Hong-Toan Lai, Romain Fernandes, Filippo G Dall'Olio, Camille Blériot, Tap Ha-Duong, Catherine Brenner

Abstract readReview
In one paragraph

Review in Cell communication and signaling : CCS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. PULSAR: a Foundation Model for Multi-scale and Multi-cellular Biology.bioRxiv : the preprint server for biology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tran Ngoc Anh NguyenAspects métaboliques et systémiques de l'oncogénèse pour de nouvelles approches thérapeutiques, CNRS, Institut Gustave Roussy, Université Paris- Saclay, Villejuif, France.
Hong-Toan LaiAspects métaboliques et systémiques de l'oncogénèse pour de nouvelles approches thérapeutiques, CNRS, Institut Gustave Roussy, Université Paris- Saclay, Villejuif, France.
Romain FernandesAspects métaboliques et systémiques de l'oncogénèse pour de nouvelles approches thérapeutiques, CNRS, Institut Gustave Roussy, Université Paris- Saclay, Villejuif, France.
Filippo G Dall'OlioAspects métaboliques et systémiques de l'oncogénèse pour de nouvelles approches thérapeutiques, CNRS, Institut Gustave Roussy, Université Paris- Saclay, Villejuif, France.
Camille BlériotAspects métaboliques et systémiques de l'oncogénèse pour de nouvelles approches thérapeutiques, CNRS, Institut Gustave Roussy, Université Paris- Saclay, Villejuif, France.
Tap Ha-DuongBioCIS, CNRS, Université Paris-Saclay, Orsay, 91400, France.
Catherine BrennerAspects métaboliques et systémiques de l'oncogénèse pour de nouvelles approches thérapeutiques, CNRS, Institut Gustave Roussy, Université Paris- Saclay, Villejuif, France. catherine.brenner@gustaveroussy.fr.

Funding

Institut National Du Cancer 2021 - 167/ INCA_16344Société des cancers de l'enfant ECS 20
6 · The paper itself

Abstract

Apoptosis-inducing factor (AIF), a mitochondrial NAD(P)H-dependent oxidoreductase, was initially studied as a cell death inducer in a process later named parthanatos. However, it has been revealed that AIF also participates in mitochondrial bioenergetics through interaction with its partner coiled-coil-helix-coiled-coil-helix domain containing 4 (CHCHD4) and involvement in mitochondrial protein import. These dual roles place AIF between pro-survival and pro-death cell fate decisions. In this review, we first describe the structure and the dual functions of AIF, highlighting its structure-function relationships. We then report previously identified AIFM1 mutations and their clinical phenotypes. Finally, we discuss the relevance of AIF in cancer and the potential of targeting this protein for the treatment of cancer.

Indexed as

Apoptosis Inducing FactorMitochondrial DiseasesNeoplasmsAnimalsApoptosisCell DeathCell SurvivalHumansMitochondriaApoptosis Inducing FactorApoptosis-inducing factor (AIF)CancerCell deathMitochondrial diseasesMitochondrial protein import

Identifiers

PMID40468311
PMCPMC12135473

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.